Receptors
-
{
- All
- News
-
NDTV Lifeline X Diabetes: Doctor Shares The Key Checks Before Prescribing Weight-Loss Injections
Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.
-
NDTV Lifeline x Diabetes: Doctor Explains The Benefits And Side-Effects Of Weight-Loss Injections For Non-Obese Diabetics
Dr Anoop Misra explains the benefits and side effects that weight loss injections pose for non-obese diabetics. Here is what you need to know about the mechanisms behind weight loss injections.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
The Gene Responsible For Vision Loss In Middle Age Discovered
According to researchers, chemical changes in the eye can lead to blindness in middle-age. Their findings aid understanding of a genetic condition that causes sight loss for one in 3,000 people in the UK.
-
What Kills Neurons After Stroke?
Researchers have found that an elusive brain receptor may play an important role in the death of neurons from neurological diseases.
-
Safer Polio Vaccine Strains For Post-Eradication Era Developed
Researchers have developed new polio vaccine strains that is particularly suitable for a post-eradication era as these strains appear both effective and unable to cause disease after accidental release.
-
Gene Mutation Behind Finns' Reckless Drunkenness: Study
Finns may have a reputation for sometimes drunken and violent behaviour but a new scientific study suggests their impulsive and reckless actions may be caused by a genetic mutation.
-
NDTV Lifeline X Diabetes: Doctor Shares The Key Checks Before Prescribing Weight-Loss Injections
Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.
-
NDTV Lifeline x Diabetes: Doctor Explains The Benefits And Side-Effects Of Weight-Loss Injections For Non-Obese Diabetics
Dr Anoop Misra explains the benefits and side effects that weight loss injections pose for non-obese diabetics. Here is what you need to know about the mechanisms behind weight loss injections.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
New Diabetes Drug Targets Metabolism, Avoids Ozempic Side Effects
Early studies suggest that it can lower blood sugar levels and increase fat burning while preserving muscle mass and normal appetite. This makes it a good option for people who struggle with the nausea, appetite loss, and muscle reduction.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Just Taking Ozempic Won't Help With Weight Loss, Daily Exercise Still Matters: New Study Warns
A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical fitness on their own. Structured exercise is essential for meaningful improvements in cardiorespiratory fitness, mobility, and lo
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
The Gene Responsible For Vision Loss In Middle Age Discovered
According to researchers, chemical changes in the eye can lead to blindness in middle-age. Their findings aid understanding of a genetic condition that causes sight loss for one in 3,000 people in the UK.
-
What Kills Neurons After Stroke?
Researchers have found that an elusive brain receptor may play an important role in the death of neurons from neurological diseases.
-
Safer Polio Vaccine Strains For Post-Eradication Era Developed
Researchers have developed new polio vaccine strains that is particularly suitable for a post-eradication era as these strains appear both effective and unable to cause disease after accidental release.
-
Gene Mutation Behind Finns' Reckless Drunkenness: Study
Finns may have a reputation for sometimes drunken and violent behaviour but a new scientific study suggests their impulsive and reckless actions may be caused by a genetic mutation.
